{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:49Z","timestamp":1792782469531,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fraunhofer-Institut f\u00fcr Toxikologie und Experimentelle Medizin ITEM","id":[{"id":"https:\/\/ror.org\/02byjcr11","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>N<\/jats:italic>\n                    -nitrosamine (NA) impurities in pharmaceuticals represent \u201ccohort of concern\u201d compounds under ICH M7(R2), due to their mutagenic\/carcinogenic potential, involving cytochrome P450 (CYP)-mediated metabolic activation. Increasing interest in mammalian cell-based genotoxicity\/mutagenicity assays prompted our assessment of the in vitro alkaline comet assay regarding its predictive power for NAs. Here, precision-cut liver slices (PCLiS), primary human hepatocytes\u00a0(PHH), primary rat hepatocytes (PRH), and HepG2 cells with rat or hamster S9-mix were investigated as in vitro model systems. Metabolic competence was characterized beforehand. For performance evaluation, a panel of known-mutagenic [\n                    <jats:italic>N<\/jats:italic>\n                    -nitroso-dimethylamine (NDMA),\n                    <jats:italic>N<\/jats:italic>\n                    -nitroso-diethanolamine,\n                    <jats:italic>N<\/jats:italic>\n                    -nitroso-methylaniline,\n                    <jats:italic>S<\/jats:italic>\n                    \u2013\n                    <jats:italic>N<\/jats:italic>\n                    -nitroso-nornicotine, N-methyl-N-nitroso-2-propanamine]\u00a0and reported non-mutagenic (methyl-t-butylnitrosamine,\n                    <jats:italic>N<\/jats:italic>\n                    -nitrosoproline) was tested, together with Nitrosamine Drug Substance-Related Impurities [\n                    <jats:italic>N<\/jats:italic>\n                    -nitrosodesloratadine,\n                    <jats:italic>N<\/jats:italic>\n                    -nitrosofolic acid,\n                    <jats:italic>N<\/jats:italic>\n                    -nitrosofluoxetine (NFluo)] at a concentration range of 0.005\u201310\u00a0mM. After 2\u00a0h (PCLiS, PHH and PRH) or 4\u00a0h (HepG2), NDMA concentration-dependently induced DNA strand breaks in all in vitro models. Sensitivity\/specificity of the various liver cell models for prediction of carcinogenic NAs were 100%\/50% (HepG2 with hamster S9-mix), 50%\/100% (PHH, PRH), and 50%\/50% (HepG2 with rat S9-mix), respectively. Benchmark dose modeling indicated a higher relative in vitro comet assay response for NFluo compared to NDMA in all cell systems. In conclusion, the in vitro comet assay represents a sensitive and\/or specific tool for complementing regulatory in vitro tests in prediction of mutagenic NAs. However, further optimization work is needed, using expanded training sets of compounds and thorough validation of liver cell models, before the in vitro comet assay could be incorporated in the standard battery for genotoxicity testing.\n                  <\/jats:p>","DOI":"10.1007\/s00204-026-04457-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:25:11Z","timestamp":1780392311000},"page":"4717-4736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The in vitro alkaline comet assay with liver models as a complementary tool for genotoxicity assessment of N-nitrosamines"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4493-1031","authenticated-orcid":false,"given":"M. A.","family":"Djuari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8268-8601","authenticated-orcid":false,"given":"A.","family":"Londenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-3144","authenticated-orcid":false,"given":"A.","family":"Bassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2462-0533","authenticated-orcid":false,"given":"K.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4714-2156","authenticated-orcid":false,"given":"L.","family":"Elenschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-527X","authenticated-orcid":false,"given":"S. E.","family":"Escher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5225-2718","authenticated-orcid":false,"given":"J.","family":"Fahrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-1346","authenticated-orcid":false,"given":"J.","family":"Fangmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8806-7387","authenticated-orcid":false,"given":"C.","family":"Felske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-7509","authenticated-orcid":false,"given":"R.","family":"Fr\u00f6tschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1213-3527","authenticated-orcid":false,"given":"B.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-9942","authenticated-orcid":false,"given":"G. E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-3900","authenticated-orcid":false,"given":"M.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-9908","authenticated-orcid":false,"given":"R.","family":"Whomsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-5385","authenticated-orcid":false,"given":"C.","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"4457_CR1","unstructured":"Organisation for Economic Co-operation and Development (2020) Ninth Addendum to OECD Guidelines for Testing of Chemicals, Section 4, No. 471 Bacterial Reverse Mutation Test. Organisation for Economic Co-operation and Development"},{"key":"4457_CR2","unstructured":"European Medicines Agency (2026) European Medicines Agency Appendix 1 to Questions and answers for marketing authorisation holders\/applicants on the CHMP Opinion for the Article 5 (3) of Regulation (EC) No 726\/2004 referral on nitrosamine impurities in human medicinal products. EMA\/CHMP\/42189\/2026\/Rev. 12"},{"key":"4457_CR3","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2023) ICH M7(R2) Guideline on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk."},{"key":"4457_CR4","unstructured":"European Medicines Agency (2025) Questions and answers for marketing authorisation holders\/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726\/2004 referral on nitrosamine impurities in human medicinal products. EMA\/409815\/2020 Rev. 23"},{"key":"4457_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0165-1161(75)90046-1","volume":"316","author":"BN Ames","year":"1975","unstructured":"Ames BN, Mc Cann J, Yamasaki E (1975) Mutation Res 316:347","journal-title":"Mutation Res"},{"key":"4457_CR6","unstructured":"European Medicines Agency (2024) European Medicines Agency Appendix 3 to Questions and answers for marketing authorisation holders\/applicants on the CHMP Opinion for the Article 5 (3) of Regulation (EC) No 726\/2004 referral on nitrosamine impurities in human medicinal products. Enhanced Ames Test Conditions for N-nitrosamines. EMA\/120337\/2024"},{"issue":"2","key":"4457_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/mutage\/10.2.85","volume":"10","author":"J Ashby","year":"1995","unstructured":"Ashby J, Tinwell H, Lefevre PA et al (1995) The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment. Mutagenesis 10(2):85\u201390. https:\/\/doi.org\/10.1093\/mutage\/10.2.85","journal-title":"Mutagenesis"},{"issue":"6","key":"4457_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00204-013-1070-0","volume":"87","author":"A Azqueta","year":"2013","unstructured":"Azqueta A, Collins AR (2013) The essential comet assay: a comprehensive guide to measuring DNA damage and repair. Arch Toxicol 87(6):949\u2013968. https:\/\/doi.org\/10.1007\/s00204-013-1070-0","journal-title":"Arch Toxicol"},{"key":"4457_CR9","unstructured":"Bache SM, Wickham H (2022) magrittr: A Forward-Pipe Operator for R. R package version 2.0.3 edn"},{"issue":"2","key":"4457_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/em.22521","volume":"64","author":"MA Beal","year":"2023","unstructured":"Beal MA, Audebert M, Barton-Maclaren T et al (2023) Quantitative in vitro to in vivo extrapolation of genotoxicity data provides protective estimates of in vivo dose. Environ Mol Mutagen 64(2):105\u2013122. https:\/\/doi.org\/10.1002\/em.22521","journal-title":"Environ Mol Mutagen"},{"key":"4457_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2025.105835","volume":"161","author":"J Bercu","year":"2025","unstructured":"Bercu J, Trejo-Martin A, Chen C et al (2025) HESI GTTC ring trial: concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions. Regul Toxicol Pharmacol 161:105835. https:\/\/doi.org\/10.1016\/j.yrtph.2025.105835","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"4457_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mc.2940070410","volume":"7","author":"AM Camus","year":"1993","unstructured":"Camus AM, Geneste O, Honkakoski P et al (1993) High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinog 7(4):268\u2013275. https:\/\/doi.org\/10.1002\/mc.2940070410","journal-title":"Mol Carcinog"},{"key":"4457_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-0716-2788-4_16","volume":"2589","author":"MJ Carlsson","year":"2023","unstructured":"Carlsson MJ, Fahrer J (2023) Analyzing the Effects of HDAC Inhibitors on DNA Damage and Associated Cytotoxicity in Primary Hepatocytes. Methods in Molecular Biology (Clifton, NJ) 2589:241\u2013252. https:\/\/doi.org\/10.1007\/978-1-0716-2788-4_16","journal-title":"Methods in Molecular Biology (Clifton, NJ)"},{"issue":"11","key":"4457_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05446-9","volume":"13","author":"MJ Carlsson","year":"2022","unstructured":"Carlsson MJ, Vollmer AS, Demuth P et al (2022) p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol. Cell Death Dis 13(11):1009. https:\/\/doi.org\/10.1038\/s41419-022-05446-9","journal-title":"Cell Death Dis"},{"issue":"6","key":"4457_CR15","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1021\/acs.chemrestox.5c00133","volume":"38","author":"MJ Carlsson","year":"2025","unstructured":"Carlsson MJ, Herzog N, Felske C et al (2025) The DNA repair protein MGMT protects against the genotoxicity of N-nitrosodimethylamine, but not N-nitrosodiethanolamine and N-nitrosomethylaniline, in human HepG2 liver cells with CYP2E1 expression. Chem Res Toxicol 38(6):1134\u20131146. https:\/\/doi.org\/10.1021\/acs.chemrestox.5c00133","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"4457_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0278-6915(99)00024-1","volume":"37","author":"MA Cheeseman","year":"1999","unstructured":"Cheeseman MA, Machuga EJ, Bailey AB (1999) A tiered approach to threshold of regulation. Food Chem Toxicol 37(4):387\u2013412. https:\/\/doi.org\/10.1016\/S0278-6915(99)00024-1","journal-title":"Food Chem Toxicol"},{"issue":"9 Pt 1","key":"4457_CR17","first-page":"3653","volume":"41","author":"C Chu","year":"1981","unstructured":"Chu C, Magee PN (1981) Metabolic fate of nitrosoproline in the rat. Cancer Res 41(9 Pt 1):3653\u20133657","journal-title":"Cancer Res"},{"issue":"5","key":"4457_CR18","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2017.4849","volume":"15","author":"ES Committee","year":"2017","unstructured":"Committee ES, Hardy A, Benford D et al (2017) Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age. EFSA J 15(5):e04849. https:\/\/doi.org\/10.2903\/j.efsa.2017.4849","journal-title":"EFSA J"},{"issue":"12","key":"4457_CR19","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.dnarep.2005.09.004","volume":"4","author":"B Demple","year":"2005","unstructured":"Demple B, Sung JS (2005) Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst) 4(12):1442\u20131449. https:\/\/doi.org\/10.1016\/j.dnarep.2005.09.004","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"4457_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00524152","volume":"69","author":"H Druckrey","year":"1967","unstructured":"Druckrey H, Preussmann R, Ivankovic S et al (1967) Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats]. Zeitschrift fur Krebsforschung 69(2):103\u2013201","journal-title":"Zeitschrift fur Krebsforschung"},{"issue":"24","key":"4457_CR21","doi-asserted-by":"publisher","first-page":"13087","DOI":"10.1073\/pnas.94.24.13087","volume":"94","author":"BP Engelward","year":"1997","unstructured":"Engelward BP, Weeda G, Wyatt MD et al (1997) Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci U S A 94(24):13087\u201313092. https:\/\/doi.org\/10.1073\/pnas.94.24.13087","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4457_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1091581810366313","volume":"29","author":"P Erkekoglu","year":"2010","unstructured":"Erkekoglu P, Baydar T (2010a) Effect of allyl isothiocyanate (AITC) in both nitrite- and nitrosamine-induced cell death, production of reactive oxygen species, and DNA damage by the single-cell gel electrophoresis (SCGE): does it have any protective effect on HepG2 cells? Int J Toxicol 29(3):305\u2013312. https:\/\/doi.org\/10.1177\/1091581810366313","journal-title":"Int J Toxicol"},{"issue":"2","key":"4457_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/15376510903583711","volume":"20","author":"P Erkekoglu","year":"2010","unstructured":"Erkekoglu P, Baydar T (2010b) Evaluation of the protective effect of ascorbic acid on nitrite- and nitrosamine-induced cytotoxicity and genotoxicity in human hepatoma line. Toxicol Mech Methods 20(2):45\u201352. https:\/\/doi.org\/10.3109\/15376510903583711","journal-title":"Toxicol Mech Methods"},{"key":"4457_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054684","author":"J Fahrer","year":"2023","unstructured":"Fahrer J, Christmann M (2023) DNA alkylation damage by nitrosamines and relevant DNA repair pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24054684","journal-title":"Int J Mol Sci"},{"key":"4457_CR26","unstructured":"U.S. Environmental Protection Agency (2012) Benchmark Dose Technical Guidance. In: Forum RA (ed). vol EPA\/100\/R-12\/001. U.S. Environmental Protection Agency,, Washington, DC"},{"issue":"2\u20133","key":"4457_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0378-4274(01)00400-3","volume":"123","author":"E Frei","year":"2001","unstructured":"Frei E, Kuchenmeister F, Gliniorz R et al (2001) N-nitrososdimethylamine is activated in microsomes from hepatocytes to reactive metabolites which damage DNA of non-parenchymal cells in rat liver. Toxicol Lett 123(2\u20133):227\u2013234. https:\/\/doi.org\/10.1016\/s0378-4274(01)00400-3","journal-title":"Toxicol Lett"},{"issue":"2","key":"4457_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","volume":"28","author":"HH Gerets","year":"2012","unstructured":"Gerets HH, Tilmant K, Gerin B et al (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28(2):69\u201387. https:\/\/doi.org\/10.1007\/s10565-011-9208-4","journal-title":"Cell Biol Toxicol"},{"key":"4457_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1289\/ehp.919611","volume":"96","author":"LS Gold","year":"1991","unstructured":"Gold LS, Slone TH, Manley NB et al (1991) The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute\/National Toxicology Program. Environ Health Perspect 96:11\u201315. https:\/\/doi.org\/10.1289\/ehp.919611","journal-title":"Environ Health Perspect"},{"issue":"4","key":"4457_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1389200033489424","volume":"4","author":"MJ Gomez-Lechon","year":"2003","unstructured":"Gomez-Lechon MJ, Donato MT, Castell JV et al (2003) Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 4(4):292\u2013312. https:\/\/doi.org\/10.2174\/1389200033489424","journal-title":"Curr Drug Metab"},{"issue":"11","key":"4457_CR31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1517\/17425255.2014.967680","volume":"10","author":"MJ Gomez-Lechon","year":"2014","unstructured":"Gomez-Lechon MJ, Tolosa L, Conde I et al (2014) Competency of different cell models to predict human hepatotoxic drugs. Expert Opin Drug Metab Toxicol 10(11):1553\u20131568. https:\/\/doi.org\/10.1517\/17425255.2014.967680","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"4457_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1517\/17425255.4.7.837","volume":"4","author":"MJ G\u00f3mez-Lech\u00f3n","year":"2008","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Cj V, Donato MT (2008) An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 4(7):837\u2013854. https:\/\/doi.org\/10.1517\/17425255.4.7.837","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4457_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tiv.2017.05.001","volume":"42","author":"A Granitzny","year":"2017","unstructured":"Granitzny A, Knebel J, Schaudien D et al (2017) Maintenance of high quality rat precision cut liver slices during culture to study hepatotoxic responses: Acetaminophen as a model compound. Toxicol in Vitro 42:200\u2013213. https:\/\/doi.org\/10.1016\/j.tiv.2017.05.001","journal-title":"Toxicol in Vitro"},{"issue":"2","key":"4457_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00204-020-02937-6","volume":"95","author":"R Gupta","year":"2021","unstructured":"Gupta R, Schrooders Y, Hauser D et al (2021) Comparing in vitro human liver models to in vivo human liver using RNA-Seq. Arch Toxicol 95(2):573\u2013589. https:\/\/doi.org\/10.1007\/s00204-020-02937-6","journal-title":"Arch Toxicol"},{"issue":"2","key":"4457_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0165-1110(87)90026-1","volume":"186","author":"JB Guttenplan","year":"1987","unstructured":"Guttenplan JB (1987) N-nitrosamines: bacterial mutagenesis and in vitro metabolism. Mutat Res 186(2):81\u2013134. https:\/\/doi.org\/10.1016\/0165-1110(87)90026-1","journal-title":"Mutat Res"},{"issue":"1","key":"4457_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00204-020-02939-4","volume":"95","author":"H Hammer","year":"2021","unstructured":"Hammer H, Schmidt F, Marx-Stoelting P et al (2021) Cross-species analysis of hepatic cytochrome P450 and transport protein expression. Arch Toxicol 95(1):117\u2013133. https:\/\/doi.org\/10.1007\/s00204-020-02939-4","journal-title":"Arch Toxicol"},{"issue":"2","key":"4457_CR37","first-page":"298","volume":"40","author":"SS Hecht","year":"1980","unstructured":"Hecht SS, C-hB C, Ohmori T et al (1980) Comparative Carcinogenicity in F344 Rats of the Tobacco-specific Nitrosamines, N\u2032-Nitrosonornicotine and 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone1. Can Res 40(2):298\u2013302","journal-title":"Can Res"},{"issue":"1","key":"4457_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/em.22338","volume":"61","author":"RH Heflich","year":"2020","unstructured":"Heflich RH, Johnson GE, Zeller A et al (2020) Mutation as a toxicological endpoint for regulatory decision-making. Environ Mol Mutagen 61(1):34\u201341. https:\/\/doi.org\/10.1002\/em.22338","journal-title":"Environ Mol Mutagen"},{"key":"4457_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105709","volume":"153","author":"RH Heflich","year":"2024","unstructured":"Heflich RH, Bishop ME, Mittelstaedt RA et al (2024) Optimizing the detection of N-nitrosamine mutagenicity in the Ames test. Regul Toxicol Pharmacol 153:105709. https:\/\/doi.org\/10.1016\/j.yrtph.2024.105709","journal-title":"Regul Toxicol Pharmacol"},{"key":"4457_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mrgentox.2018.01.010","volume":"827","author":"YH Hong","year":"2018","unstructured":"Hong YH, Jeon HL, Ko KY et al (2018) Assessment of the predictive capacity of the optimized in vitro comet assay using HepG2 cells. Mutat Res Genet Toxicol Environ Mutagen 827:59\u201367. https:\/\/doi.org\/10.1016\/j.mrgentox.2018.01.010","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"3","key":"4457_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: a 2D graphics environment. Comput Sci Eng 9(3):90\u201395","journal-title":"Comput Sci Eng"},{"key":"4457_CR42","volume-title":"IARC monographs on the evaluation of the evaluation of the carcinogenic risks to humans","author":"IARC","year":"1987","unstructured":"IARC (1987) IARC monographs on the evaluation of the evaluation of the carcinogenic risks to humans, vol vol Supplement 7. International Agengy for Research on Cancer, Lyon"},{"key":"4457_CR43","first-page":"403","volume-title":"Some industrial chemicals - IARC monographs on the evaluation of carcinogenic risks to humans. Some industrial chemicals some industrial chemicals - IARC monographs on the evaluation of carcinogenic risks to humans some industrial chemicals","author":"IARC","year":"2000","unstructured":"IARC (2000) Some industrial chemicals - IARC monographs on the evaluation of carcinogenic risks to humans. Some industrial chemicals some industrial chemicals - IARC monographs on the evaluation of carcinogenic risks to humans some industrial chemicals, vol 77. International Agency for Research on Cancer, Lyon, pp 403\u2013438"},{"key":"4457_CR44","unstructured":"IARC (2007) Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 89"},{"issue":"5","key":"4457_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/em.22446","volume":"62","author":"GE Johnson","year":"2021","unstructured":"Johnson GE, Dobo K, Gollapudi B et al (2021) Permitted daily exposure limits for noteworthy N-nitrosamines. Environ Mol Mutagen 62(5):293\u2013305. https:\/\/doi.org\/10.1002\/em.22446","journal-title":"Environ Mol Mutagen"},{"key":"4457_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105672","volume":"152","author":"RA Jolly","year":"2024","unstructured":"Jolly RA, Cornwell PD, Noteboom J et al (2024) Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine. Regul Toxicol Pharmacol 152:105672. https:\/\/doi.org\/10.1016\/j.yrtph.2024.105672","journal-title":"Regul Toxicol Pharmacol"},{"issue":"21","key":"4457_CR47","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00018-010-0491-7","volume":"67","author":"B Kaina","year":"2010","unstructured":"Kaina B, Margison GP, Christmann M (2010) Targeting O6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy. Cell Mol Life Sci 67(21):3663\u20133681. https:\/\/doi.org\/10.1007\/s00018-010-0491-7","journal-title":"Cell Mol Life Sci"},{"key":"4457_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mrgentox.2019.01.007","volume":"839","author":"D Kirkland","year":"2019","unstructured":"Kirkland D, Levy DD, LeBaron MJ et al (2019) A comparison of transgenic rodent mutation and in vivo comet assay responses for 91 chemicals. Mutat Res Genet Toxicol Environ Mutagen 839:21\u201335. https:\/\/doi.org\/10.1016\/j.mrgentox.2019.01.007","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"3","key":"4457_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-3835(85)90185-5","volume":"27","author":"SR Koepke","year":"1985","unstructured":"Koepke SR, Tondeur Y, Farrelly JG et al (1985) Metabolic studies of 15N-labeled N-nitrosoproline in isolated rat hepatocytes and subcellular fractions. Cancer Lett 27(3):277\u2013283. https:\/\/doi.org\/10.1016\/0304-3835(85)90185-5","journal-title":"Cancer Lett"},{"issue":"8","key":"4457_CR50","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/carcin\/bgab049","volume":"42","author":"T Kostka","year":"2021","unstructured":"Kostka T, Empl MT, Seiwert N et al (2021) Repair of O6-carboxymethylguanine adducts by O6-methylguanine-DNA methyltransferase in human colon epithelial cells. Carcinogenesis 42(8):1110\u20131118. https:\/\/doi.org\/10.1093\/carcin\/bgab049","journal-title":"Carcinogenesis"},{"issue":"2","key":"4457_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/carcin\/4.2.157","volume":"4","author":"MB Kroeger-Koepke","year":"1983","unstructured":"Kroeger-Koepke MB, Reuber MD, Iype PT et al (1983) The effect of substituents in the aromatic ring on carcinogenicity of N-nitrosomethylaniline in F344 rats. Carcinogenesis 4(2):157\u2013160. https:\/\/doi.org\/10.1093\/carcin\/4.2.157","journal-title":"Carcinogenesis"},{"issue":"1","key":"4457_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.fct.2003.08.006","volume":"42","author":"R Kroes","year":"2004","unstructured":"Kroes R, Renwick AG, Cheeseman M et al (2004) Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol 42(1):65\u201383. https:\/\/doi.org\/10.1016\/j.fct.2003.08.006","journal-title":"Food Chem Toxicol"},{"key":"4457_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105640","volume":"150","author":"NL Kruhlak","year":"2024","unstructured":"Kruhlak NL, Schmidt M, Froetschl R et al (2024) Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: development and application of the Carcinogenic Potency Categorization Approach (CPCA). Regul Toxicol Pharmacol 150:105640. https:\/\/doi.org\/10.1016\/j.yrtph.2024.105640","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1\u20133","key":"4457_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2005.04.002","volume":"590","author":"IB Lambert","year":"2005","unstructured":"Lambert IB, Singer TM, Boucher SE et al (2005) Detailed review of transgenic rodent mutation assays. Mutat Res 590(1\u20133):1\u2013280. https:\/\/doi.org\/10.1016\/j.mrrev.2005.04.002","journal-title":"Mutat Res"},{"issue":"9","key":"4457_CR55","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.3390\/ijms23094559","volume":"23","author":"Y Li","year":"2022","unstructured":"Li Y, Hecht SS (2022a) Metabolic activation and DNA interactions of carcinogenic N-Nitrosamines to which humans are commonly exposed. Int J Mol Sci 23(9):4559. https:\/\/doi.org\/10.3390\/ijms23094559","journal-title":"Int J Mol Sci"},{"key":"4457_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094559","author":"Y Li","year":"2022","unstructured":"Li Y, Hecht SS (2022b) Metabolic activation and DNA interactions of carcinogenic N-Nitrosamines to which humans are commonly exposed. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094559","journal-title":"Int J Mol Sci"},{"key":"4457_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-022-03347-6","author":"X Li","year":"2022","unstructured":"Li X, He X, Le Y et al (2022) Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-022-03347-6","journal-title":"Arch Toxicol"},{"key":"4457_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105730","volume":"154","author":"X Li","year":"2024","unstructured":"Li X, Le Y, Guo X et al (2024) Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells. Regul Toxicol Pharmacol 154:105730. https:\/\/doi.org\/10.1016\/j.yrtph.2024.105730","journal-title":"Regul Toxicol Pharmacol"},{"key":"4457_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mrgentox.2014.10.008","volume":"783","author":"JT MacGregor","year":"2015","unstructured":"MacGregor JT, Frotschl R, White PA et al (2015a) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res Genet Toxicol Environ Mutagen 783:66\u201378. https:\/\/doi.org\/10.1016\/j.mrgentox.2014.10.008","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"4457_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mrgentox.2014.09.011","volume":"783","author":"JT MacGregor","year":"2015","unstructured":"MacGregor JT, Frotschl R, White PA et al (2015b) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). Mutat Res Genet Toxicol Environ Mutagen 783:55\u201365. https:\/\/doi.org\/10.1016\/j.mrgentox.2014.09.011","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"3","key":"4457_CR61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/em.2860080311","volume":"8","author":"E Madle","year":"1986","unstructured":"Madle E, Tiedemann G, Madle S et al (1986) Comparison of S9 mix and hepatocytes as external metabolizing systems in mammalian cell cultures: cytogenetic effects of 7,12-dimethylbenzanthracene and aflatoxin B1. Environ Mutagen 8(3):423\u2013437. https:\/\/doi.org\/10.1002\/em.2860080311","journal-title":"Environ Mutagen"},{"issue":"3\u20134","key":"4457_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-1161(83)90010-9","volume":"113","author":"DM Maron","year":"1983","unstructured":"Maron DM, Ames BN (1983) Revised methods for the Salmonella mutagenicity test. Mutat Res Environ Mutagen Relat Subj 113(3\u20134):173\u2013215. https:\/\/doi.org\/10.1016\/0165-1161(83)90010-9","journal-title":"Mutat Res Environ Mutagen Relat Subj"},{"issue":"3","key":"4457_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1077","volume":"48","author":"LP Ngo","year":"2020","unstructured":"Ngo LP, Owiti NA, Swartz C et al (2020) Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates. Nucleic Acids Res 48(3):e13. https:\/\/doi.org\/10.1093\/nar\/gkz1077","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4457_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0015-6264(76)80257-x","volume":"14","author":"JE Nixon","year":"1976","unstructured":"Nixon JE, Wales JH, Scanlan RA et al (1976) Null carcinogenic effect of large doses of nitrosoproline and nitrosohydroxyproline in Wistar rats. Food Cosmet Toxicol 14(2):133\u2013135. https:\/\/doi.org\/10.1016\/s0015-6264(76)80257-x","journal-title":"Food Cosmet Toxicol"},{"key":"4457_CR65","unstructured":"Organisation for Economic Co-operation and Development (2022) Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays,"},{"issue":"10","key":"4457_CR66","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1021\/acs.oprd.3c00100","volume":"27","author":"R Nudelman","year":"2023","unstructured":"Nudelman R, Kocks G, Mouton B et al (2023) The Nitrosamine \u201csaga\u201d: lessons learned from five years of scrutiny. Org Process Res Dev 27(10):1719\u20131735. https:\/\/doi.org\/10.1021\/acs.oprd.3c00100","journal-title":"Org Process Res Dev"},{"key":"4457_CR67","unstructured":"OECD (2016) GUIDELINE FOR THE TESTING OF CHEMICALS No. 489 In Vivo Mammalian Alkaline Comet Assay"},{"issue":"1","key":"4457_CR68","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0006-291x(84)90411-x","volume":"123","author":"O Ostling","year":"1984","unstructured":"Ostling O, Johanson KJ (1984) Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123(1):291\u2013298. https:\/\/doi.org\/10.1016\/0006-291x(84)90411-x","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4457_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0168-8278(00)00085-4","volume":"34","author":"X Ponsoda","year":"2001","unstructured":"Ponsoda X, Pareja E, G\u00f3mez-Lech\u00f3n M-J et al (2001) Drug biotransformation by human hepatocytes. in vitro\/in vivo metabolism by cells from the same donor. J Hepatol 34(1):19\u201325. https:\/\/doi.org\/10.1016\/S0168-8278(00)00085-4","journal-title":"J Hepatol"},{"key":"4457_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105681","volume":"152","author":"MW Powley","year":"2024","unstructured":"Powley MW, Sobol Z, Johnson GE et al (2024) N-nitrosamine impurity risk assessment in pharmaceuticals: utilizing in vivo mutation relative potency comparison to establish an acceptable intake for NTTP. Regul Toxicol Pharmacol 152:105681. https:\/\/doi.org\/10.1016\/j.yrtph.2024.105681","journal-title":"Regul Toxicol Pharmacol"},{"key":"4457_CR71","first-page":"477","volume":"84","author":"S Preston-Martin","year":"1987","unstructured":"Preston-Martin S (1987) N-nitroso compounds as a cause of human cancer. IARC Sci Publ 84:477\u2013484","journal-title":"IARC Sci Publ"},{"key":"4457_CR72","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2022","unstructured":"R Core Team (2022) R: a language and environment for statistical computing, vol 4.2.2. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"4457_CR73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2013.01.028","volume":"60","author":"AA Ramos","year":"2013","unstructured":"Ramos AA, Pedro DFN, Lima CF et al (2013) Development of a new application of the comet assay to assess levels of O6-methylguanine in genomic DNA (CoMeth). Free Radic Biol Med 60:41\u201348. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.028","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"4457_CR74","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/ol.2011.417","volume":"3","author":"M Reiter","year":"2012","unstructured":"Reiter M, Baumeister P, Jaiser S et al (2012) DNA repair and mutagen sensitivity of epithelial cells and lymphocytes in oropharyngeal cancer. Oncol Lett 3(1):100\u2013106. https:\/\/doi.org\/10.3892\/ol.2011.417","journal-title":"Oncol Lett"},{"key":"4457_CR75","unstructured":"RIVM (2021) PROAST Manual version 70.3."},{"key":"4457_CR76","unstructured":"RIVM National Institute for Public Health and the Environment PROAST. 70.3 edn"},{"key":"4457_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2020.106539","volume":"271","author":"T Salam","year":"2021","unstructured":"Salam T, Lyngdoh RHD (2021) Clues to the non-carcinogenicity of certain N-Nitroso compounds: role of alkylated DNA bases. Biophys Chem 271:106539. https:\/\/doi.org\/10.1016\/j.bpc.2020.106539","journal-title":"Biophys Chem"},{"issue":"6","key":"4457_CR78","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/10408440008951123","volume":"30","author":"YF Sasaki","year":"2000","unstructured":"Sasaki YF, Sekihashi K, Izumiyama F et al (2000) The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database. Crit Rev Toxicol 30(6):629\u2013799. https:\/\/doi.org\/10.1080\/10408440008951123","journal-title":"Crit Rev Toxicol"},{"key":"4457_CR79","doi-asserted-by":"publisher","unstructured":"Sasaki YF (2018) Detection of in vitro genotoxicity of pro-mutagens using the comet assay under human and rat liver S9 fractions. MOJ Toxicology 4(4) https:\/\/doi.org\/10.15406\/mojt.2018.04.00109","DOI":"10.15406\/mojt.2018.04.00109"},{"issue":"5","key":"4457_CR80","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00204-019-02406-9","volume":"93","author":"JE Seo","year":"2019","unstructured":"Seo JE, Tryndyak V, Wu Q et al (2019) Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay. Arch Toxicol 93(5):1433\u20131448. https:\/\/doi.org\/10.1007\/s00204-019-02406-9","journal-title":"Arch Toxicol"},{"issue":"10","key":"4457_CR81","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s00204-023-03560-x","volume":"97","author":"J-E Seo","year":"2023","unstructured":"Seo J-E, Yu JZ, Xu H et al (2023) Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models. Arch Toxicol 97(10):2785\u20132798. https:\/\/doi.org\/10.1007\/s00204-023-03560-x","journal-title":"Arch Toxicol"},{"issue":"6","key":"4457_CR82","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00204-024-03731-4","volume":"98","author":"J-E Seo","year":"2024","unstructured":"Seo J-E, Le Y, Revollo J et al (2024) Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing. Arch Toxicol 98(6):1919\u20131935. https:\/\/doi.org\/10.1007\/s00204-024-03731-4","journal-title":"Arch Toxicol"},{"key":"4457_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2025.105906","volume":"162","author":"J-E Seo","year":"2025","unstructured":"Seo J-E, Xu H, Li X et al (2025a) Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models. Regul Toxicol Pharmacol 162:105906. https:\/\/doi.org\/10.1016\/j.yrtph.2025.105906","journal-title":"Regul Toxicol Pharmacol"},{"key":"4457_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111538","volume":"416","author":"JE Seo","year":"2025","unstructured":"Seo JE, He X, Bryant M et al (2025b) Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes. Chem Biol Interact 416:111538. https:\/\/doi.org\/10.1016\/j.cbi.2025.111538","journal-title":"Chem Biol Interact"},{"issue":"1","key":"4457_CR85","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh NP, McCoy MT, Tice RR et al (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175(1):184\u2013191. https:\/\/doi.org\/10.1016\/0014-4827(88)90265-0","journal-title":"Exp Cell Res"},{"issue":"7","key":"4457_CR86","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3109\/10408444.2014.925424","volume":"44","author":"W Slob","year":"2014","unstructured":"Slob W (2014) Benchmark dose and the three Rs. Part II. consequences for study design and animal use. Crit Rev Toxicol 44(7):568\u2013580. https:\/\/doi.org\/10.3109\/10408444.2014.925424","journal-title":"Crit Rev Toxicol"},{"issue":"3","key":"4457_CR87","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/10408444.2013.853726","volume":"44","author":"W Slob","year":"2014","unstructured":"Slob W, Setzer RW (2014) Shape and steepness of toxicological dose-response relationships of continuous endpoints. Crit Rev Toxicol 44(3):270\u2013297. https:\/\/doi.org\/10.3109\/10408444.2013.853726","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4457_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3233\/jcb-189013","volume":"5","author":"S Steinbrecht","year":"2019","unstructured":"Steinbrecht S, Kammerer S, K\u00fcpper J-H (2019) HepG2 cells with recombinant cytochrome P450 enzyme overexpression: their use and limitation as in vitro liver model. J Cell Biotechnol 5(1):55\u201364. https:\/\/doi.org\/10.3233\/jcb-189013","journal-title":"J Cell Biotechnol"},{"key":"4457_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105460","volume":"143","author":"RE Tennant","year":"2023","unstructured":"Tennant RE, Ponting DJ, Thresher A (2023) A deep dive into historical Ames study data for N-nitrosamine compounds. Regul Toxicol Pharmacol 143:105460. https:\/\/doi.org\/10.1016\/j.yrtph.2023.105460","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"4457_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/mutage\/gead033","volume":"39","author":"DN Thomas","year":"2024","unstructured":"Thomas DN, Wills JW, Tracey H et al (2024) Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters. Mutagenesis 39(2):78\u201395. https:\/\/doi.org\/10.1093\/mutage\/gead033","journal-title":"Mutagenesis"},{"issue":"2","key":"4457_CR91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/mutage\/geae027","volume":"40","author":"DN Thomas","year":"2025","unstructured":"Thomas DN, Wills JW, Burman M et al (2025a) Resolution of historically discordant Ames test negative\/rodent carcinogenicity positive N-nitrosamines using a sensitive, OECD-aligned design. Mutagenesis 40(2):116\u2013125. https:\/\/doi.org\/10.1093\/mutage\/geae027","journal-title":"Mutagenesis"},{"issue":"3","key":"4457_CR92","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00204-024-03951-8","volume":"99","author":"R Thomas","year":"2025","unstructured":"Thomas R, Ponting DJ, Thresher A et al (2025b) Critical comparison of BMD and TD50 methods for the calculation of acceptable intakes for N-nitroso compounds. Arch Toxicol 99(3):983\u2013993. https:\/\/doi.org\/10.1007\/s00204-024-03951-8","journal-title":"Arch Toxicol"},{"key":"4457_CR93","unstructured":"U.S. Food & Drug Administration (2023) CDER Nitrosamine Impurity Acceptable Intake Limits. In. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cder-nitrosamine-impurity-acceptable-intake-limits Accessed 01.09.2025 2025"},{"issue":"2","key":"4457_CR94","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s1383-5718(00)00051-6","volume":"468","author":"M Uhl","year":"2000","unstructured":"Uhl M, Helma C, Knasmuller S (2000) Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells. Mutat Res 468(2):213\u2013225. https:\/\/doi.org\/10.1016\/s1383-5718(00)00051-6","journal-title":"Mutat Res"},{"key":"4457_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2026.106036","author":"M Vogel","year":"2026","unstructured":"Vogel M, Carlsson MJ, Skowron C et al (2026) Nitrosamine drug substance-related impurities cause DNA methylation adducts in vitro and in primary hepatocytes upon Cytochrome P450-dependend metabolic activation. Regul Toxicol Pharmacol. https:\/\/doi.org\/10.1016\/j.yrtph.2026.106036","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"4457_CR96","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00204-017-2109-4","volume":"92","author":"M Waldherr","year":"2018","unstructured":"Waldherr M, Misik M, Ferk F et al (2018) Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals? Arch Toxicol 92(2):921\u2013934. https:\/\/doi.org\/10.1007\/s00204-017-2109-4","journal-title":"Arch Toxicol"},{"key":"4457_CR97","doi-asserted-by":"crossref","unstructured":"Waskom M (2021) seaborn: statistical data visualization Journal of Open Source Software. vol 6, 0.11.2 edn","DOI":"10.21105\/joss.03021"},{"issue":"1","key":"4457_CR98","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/em.22351","volume":"61","author":"PA White","year":"2020","unstructured":"White PA, Long AS, Johnson GE (2020) Quantitative interpretation of genetic toxicity dose-response data for risk assessment and regulatory decision-making: current status and emerging priorities. Environ Mol Mutagen 61(1):66\u201383. https:\/\/doi.org\/10.1002\/em.22351","journal-title":"Environ Mol Mutagen"},{"key":"4457_CR99","doi-asserted-by":"publisher","unstructured":"White PA, Zeller A, Pfuhler S, et al. (2019) Re: Gi et al. 2018, In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats, Archives of Toxicology 92:3207\u20133221. Archives of toxicology 93(1):211\u2013212 https:\/\/doi.org\/10.1007\/s00204-018-2370-1","DOI":"10.1007\/s00204-018-2370-1"},{"key":"4457_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) Ggplot2: elegant graphics for data analysis, 2 edn. Springer International Publishing, Cham, Switzerland","edition":"2 edn"},{"issue":"8","key":"4457_CR101","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","volume":"31","author":"S Wilkening","year":"2003","unstructured":"Wilkening S, Stahl F, Bader A (2003) Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 31(8):1035\u20131042. https:\/\/doi.org\/10.1124\/dmd.31.8.1035","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"4457_CR102","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/mutage\/gev085","volume":"31","author":"JW Wills","year":"2016","unstructured":"Wills JW, Johnson GE, Doak SH et al (2016a) Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations. Mutagenesis 31(3):255\u2013263. https:\/\/doi.org\/10.1093\/mutage\/gev085","journal-title":"Mutagenesis"},{"issue":"3","key":"4457_CR103","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/mutage\/gew009","volume":"31","author":"JW Wills","year":"2016","unstructured":"Wills JW, Long AS, Johnson GE et al (2016b) Empirical analysis of BMD metrics in genetic toxicology part II: in vivo potency comparisons to promote reductions in the use of experimental animals for genetic toxicity assessment. Mutagenesis 31(3):265\u2013275. https:\/\/doi.org\/10.1093\/mutage\/gew009","journal-title":"Mutagenesis"},{"issue":"2","key":"4457_CR104","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mrgentox.2008.08.012","volume":"657","author":"HK Winter","year":"2008","unstructured":"Winter HK, Ehrlich VA, Grusch M et al (2008) Use of four new human-derived liver-cell lines for the detection of genotoxic compounds in the single-cell gel electrophoresis (SCGE) assay. Mutat Res 657(2):133\u2013139. https:\/\/doi.org\/10.1016\/j.mrgentox.2008.08.012","journal-title":"Mutat Res"},{"issue":"10","key":"4457_CR105","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/carcin\/13.10.1789","volume":"13","author":"H Yamazaki","year":"1992","unstructured":"Yamazaki H, Inui Y, Yun CH et al (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13(10):1789\u20131794. https:\/\/doi.org\/10.1093\/carcin\/13.10.1789","journal-title":"Carcinogenesis"},{"issue":"2","key":"4457_CR106","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/mutage\/gey005","volume":"33","author":"A Zeller","year":"2018","unstructured":"Zeller A, Pfuhler S, Albertini S et al (2018) A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens. Mutagenesis 33(2):179\u2013193. https:\/\/doi.org\/10.1093\/mutage\/gey005","journal-title":"Mutagenesis"},{"issue":"1","key":"4457_CR107","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0027-5107(88)90189-3","volume":"202","author":"M Zielenska","year":"1988","unstructured":"Zielenska M, Guttenplan JB (1988) Mutagenic activity and specificity of N-nitrosomethylaniline and N-nitrosodiphenylamine in Salmonella. Mutat Res 202(1):269\u2013276. https:\/\/doi.org\/10.1016\/0027-5107(88)90189-3","journal-title":"Mutat Res"},{"key":"4457_CR108","unstructured":"International Council for Harmonisation. (2011). ICH harmonised guideline: S2(R1) Genotoxicity testing and data interpretation for pharmaceuticals intended for human use (Current Step 4 version). https:\/\/database.ich.org\/sites\/default\/files\/S2%28R1%29%20Guideline.pdf"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04457-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:06:55Z","timestamp":1790060815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04457-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4457"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04457-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This document expresses the opinion of the authors of the paper and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties. A.B. & G.E.J. are consultants who evaluate the risks posed by pharmaceutical impurities. Their clients did not influence the content of this manuscript. Other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}